We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Magnetic Nanoparticles Simultaneously Diagnose, Monitor, and Treat Diseases

By LabMedica International staff writers
Posted on 21 Nov 2009
Tiny magnetic nanoparticles (mNPs) and external magnetic forces create a medical means to confirm specific ailments and automatically release healing drugs while inside a living system. More...
For example, mNPs can direct ”therapeutically armed” white blood cells to invade a tumor's territory, or they can target specific nerve channels and induce nerve-led behavior (such as heart beating).

The magnetic component of the direction-giving nanoparticles is usually an iron-based compound called ferric oxide, which is coated in a biocompatible surface, sometimes using, for example, fatty acids, to provide stability during the particles journey through the body. For biomedicine, the particles are useful because specific signal triggering molecules can be added to identify certain conditions, or dyes to help in medical imaging, or therapeutic agents to remedy a wide range of conditions.

Multifunctional particles, modeled on viral particles such as the flu and human immunodeficiency virus (HIV), are being studied and developed to carry signal-generating sub-molecules and drugs.

A number of review articles dealing with progress in the use of mNPs in biomedicine as well as their future prospects were published on November 6, 2009 in IOP Publishing's Journal of Physics D.

Professor Q. Pankhurst from the department of physics and astronomy at the University College London (UK) and colleagues were authors of one of the reviews, which dealt with the progress in applications of mNPs. In their conclusion they wrote, "there is a lot of activity in this field, and the future is bright, so long as we pay attention to the primary criteria for success, making sure that there is a clearly identified clinical need that can be addressed, and addressed in a way that can be quantified or assessed to the satisfaction of the relevant licensing bodies.''

Related Links:

University College London



Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Rapid Molecular Testing Device
FlashDetect Flash10
Gel Cards
DG Gel Cards
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: DROP-AD in-house collection and extraction protocol and testing procedures (Huber, H., Montoliu-Gaya, L., Brum, W.S. et al.; Nat Med (20256); doi.org/10.1038/s41591-025-04080-0)

At-Home Blood Tests Accurately Detect Key Alzheimer's Biomarkers

Diagnosing Alzheimer’s disease typically relies on brain scans or spinal fluid tests, which are invasive, costly, and difficult to access outside specialist clinics. These barriers have limited large-scale... Read more

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.